 current statu cyclosporin treatment membran iga membranoprolif glomerulonephr effect cyclosporin cya sandimmun therapi variou type primari glomerular diseas membran nephropathi data posit effect disord control risk-benefit ratio need adjunct therapi steroid term time respons durat respons risk nephrotox need function patholog perspect proper prospect trial safeti efficaci cya diseas iga membranoprolif glomerulonephr data spars isol studi benefit categori risk evid care pilot studi conclus regard use agent disord